The reduced percentage of circulating CX3CR1+ NK cells in SSc patients may be due to their recruitment to target tissues in response to upregulation of CX3CL1 and NKG2D ligands in the inflamed endothelium. This evidence concerns the gene CX3CR1 and systemic sclerosis.